| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190185 Plant extract mixtures and their uses |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | US20070190040 Recombinant p53 adenovirus methods and compositions |
| 08/16/2007 | US20070190021 Poly(diallylamine)-based bile acid sequestrants |
| 08/16/2007 | DE60127731T2 Probiotica zur Verwendung als Futter für Haustiere Probiotics for use as food for pets |
| 08/16/2007 | CA2642665A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | CA2641638A1 A direct cellular energy delivery system |
| 08/16/2007 | CA2641588A1 Stabilized compositions of proteins having a free thiol moiety |
| 08/16/2007 | CA2641546A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease |
| 08/16/2007 | CA2625981A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/15/2007 | EP1818408A1 Serotype of adenovirus and uses thereof |
| 08/15/2007 | EP1818342A2 Purified primate CTLA-8 antigens and related reagents |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1718641B1 Benzimidazole derivative and its use as a ii receptor antagonist |
| 08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
| 08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor |
| 08/15/2007 | EP1368372B1 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | EP1363668B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1328288B1 Protein mixtures for wound healing |
| 08/15/2007 | EP1259242B1 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | EP1252171B1 Method for preparing functionalised beta-(1,3)-glucan derivatives |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1196174B1 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331491C Ginseng and aconite transfusion for treating qi vacuity and yang desertion and its preparation method |
| 08/15/2007 | CN1331463C Method for chemo-prevention of prostate cancer |
| 08/15/2007 | CN101018853A Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018787A Ligands for G-protein coupled receptors |
| 08/15/2007 | CN101018782A Hydantoin compound for the treatment of inflammatory disorders |
| 08/15/2007 | CN101018557A Carbohydrase inhibitors derived from chestnut and use thereof |
| 08/15/2007 | CN101018551A Porphyrin derivatives and their use in photon activation therapy |
| 08/15/2007 | CN101018537A Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 08/15/2007 | CN101016262A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 08/15/2007 | CN101015353A Pure natural oxygenation health care beverage and compounding process thereof |
| 08/15/2007 | CN101015350A Senescence delaying health care composition |
| 08/15/2007 | CN101015315A Cedar leaf tea preparation and its preparing process |
| 08/15/2007 | CN101015312A Health care functional tea for conditioning subhealthy state |
| 08/14/2007 | US7256307 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR) |
| 08/14/2007 | US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 08/14/2007 | US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |
| 08/14/2007 | US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease. |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256178 Physiologically active substances |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7255984 Combination therapy for osteoporosis |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/14/2007 | CA2370030C Sodium channel blocker compositions and the use thereof |
| 08/14/2007 | CA2281708C Process for preparing eprosartan |
| 08/14/2007 | CA2251016C .alpha.1-adrenergic receptor antagonists |
| 08/14/2007 | CA2223414C Heteroaryl diol acids as leukotriene antagonists |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007089166A1 Medicinal preparation for jugulating a systemic inflammatory response syndrome |
| 08/09/2007 | WO2007088895A1 3-arylamino-1,2,4-triazole derivative |
| 08/09/2007 | WO2007088869A1 Method for producing denatured substance of lactalbumin |
| 08/09/2007 | WO2007088830A1 Novel peptide and therapeutic agent for endotoxin-induced disease using the same |
| 08/09/2007 | WO2007088823A1 ABZYME TO HUMAN TNF-α AND USE THEREOF |
| 08/09/2007 | WO2007088712A1 Neuronal cell death inhibitor and screening method |
| 08/09/2007 | WO2007088651A1 JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT |
| 08/09/2007 | WO2007062875B1 Heteroaromatic sulfonamide prodrugs |
| 08/09/2007 | WO2005123725A9 Novel compound having lipase inhibitory activity |
| 08/09/2007 | US20070185195 Hyperuricemia; uricosuric agents, which have potent uricosuric effect and do not cause grave hepatic disorder; against the uptake of uric acid in kidney |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors |
| 08/09/2007 | US20070185168 Piperidine derivatives |
| 08/09/2007 | US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 08/09/2007 | US20070185134 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 08/09/2007 | US20070185131 Heterocyclic Compounds |
| 08/09/2007 | US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
| 08/09/2007 | US20070185082 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 08/09/2007 | US20070185022 Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products |
| 08/09/2007 | US20070185013 Use of chk1 inhibitors to control cell proliferation |
| 08/09/2007 | US20070184477 Anti-HIV Agent |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/09/2007 | US20070183975 Polypeptide absorbable into digestive organs |